PLATINUM INVESTMENT MANAGEMENT LTD
Position in BBIO — BridgeBio Pharma, Inc.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in BBIO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,658,715
+$5,859 QoQ
Shares Held
49,269
+3.2% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $70,718,725 across 29 Biotechnology names. BBIO ranks #8 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
110,734 | $5,837,896 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
137,741 | $5,471,072 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $4,908,289 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,573,628 | |
| 5 | IMVT |
Immunovant, Inc.
|
181,774 | $4,515,266 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
112,066 | $4,313,420 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $4,059,950 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
This page
|
49,269 | $3,658,715 |
All Filings in BBIO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,658,715 | 49,269 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,652,856 | 47,756 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,232,953 | 62,244 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,269,071 | 75,708 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $2,431,999 | 70,350 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||